The reason for the reduced VNN2 expression in the biological response of M-MDSCs to gliomas has not yet been investigated, but the detection of CD14+/VNN2high MDSCs in peripheral blood is considered an additional useful marker in the diagnostic spectrum of tumor diagnosis [73]. The gene discussed is CD14; the disease is central nervous system cancer.